Friday, February 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

MicroStrategy Faces Setback as S&P 500 Exclusion Overshadows Bitcoin Strategy

Robert Sasse by Robert Sasse
September 10, 2025
in Bitcoin, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
185
VIEWS
Share on FacebookShare on Twitter

MicroStrategy’s bid to join the prestigious S&P 500 index has been denied, a significant blow to the enterprise software firm and its investors. Despite meeting the index’s formal criteria for market capitalization and recent profitability, the selection committee opted to include Robinhood and AppLovin instead. This decision dashes hopes for billions in potential passive investment inflows and raises questions about the sustainability of the company’s aggressive Bitcoin acquisition plan.

Persistent Bitcoin Accumulation Amid Shareholder Dilution

Undeterred by the setback, CEO Michael Saylor continues to execute the company’s core strategy. In the first week of September, MicroStrategy purchased an additional 1,955 Bitcoin for approximately $217.4 million. This latest acquisition brings the company’s total holdings to a staggering 638,460 BTC, with a market value of $47.17 billion. The average purchase price per coin stands at $73,880.

The purchase was primarily financed through the sale of equity, with $200.5 million raised from issuing new shares. This method of funding, while effective for accumulating Bitcoin, applies downward pressure on the stock by diluting the value for existing shareholders—a contributing factor to the share price’s recent weakness.

Index Snub Highlights Underlying Volatility Concerns

The S&P 500 committee’s decision appears to be rooted in risk assessment. Analysts suggest that MicroStrategy’s extreme stock volatility was a key deterrent. The stock boasts a beta of 3.83, meaning it tends to move nearly 4% for every 1% movement in the broader market. This level of volatility eclipses even that of other high-growth tech stocks like Nvidia and Tesla, presenting a risk profile seemingly too high for the committee’s comfort.

The exclusion is more than a symbolic snub; it has tangible financial consequences. The company is now set to miss out on an estimated $10 to $16 billion in potential passive investment that typically follows inclusion in the major index.

Should investors sell immediately? Or is it worth buying Strategy?

Mixed Analyst Sentiment Reflects Strategic Dilemma

Wall Street remains divided on MicroStrategy’s prospects. Benchmark recently reaffirmed its Buy rating with a $705 price target. Positive outlooks are also held by Canaccord Genuity and Mizuho. The average analyst price target for the stock sits around $564.

However, a fundamental challenge persists: the stock’s performance is inextricably linked to the price of Bitcoin. This tight correlation makes the company uniquely vulnerable to swings in the cryptocurrency market. Furthermore, investors are increasingly scrutinizing the significant premium of MicroStrategy’s market capitalization over the net asset value of its Bitcoin treasury.

Sustained Downtrend Despite Bullish Moves

Despite continuous Bitcoin buying and some supportive analyst views, MicroStrategy’s share price remains in a pronounced downtrend. This recent weakness coincides with the latest round of share issuance, highlighting the difficult position the company is in.

Its core strategy of aggressive Bitcoin accumulation is creating a feedback loop: each new purchase financed by equity dilutes shareholders and exerts additional selling pressure on the stock. MicroStrategy finds itself caught between its unwavering commitment to its Bitcoin strategy and the punishing realities of the equity market.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from February 6 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 6.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

S&P 500 Stock
Market Commentary

US Benchmark Index Breaches Key Threshold Amid Tech and Jobs Concerns

February 6, 2026
Bitcoin Stock
Bitcoin

Bitcoin Plummets Amidst Widespread Market Liquidation

February 6, 2026
BitMine Stock
Analysis

BitMine’s Aggressive Crypto Strategy Faces Investor Scrutiny

February 5, 2026
Next Post
Marvell Technology Stock

Trust Recognition Fuels Marvell Technology's Market Momentum

Micron Stock

Micron Technology's AI-Driven Resurgence Captivates Markets

Meta Stock

Meta's $140 Million AI Vision Faces Regulatory Hurdles

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com